Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging in Japanese hypertrophic cardiomyopathy patients

Circulation Journal

Volumn 78, Issue 4, 2014, Pages 929-937

  Hen, Yasuki ^a   Iguchi, Nobuo ^a   Utanohara, Yuko ^a   Takada, Kaori ^b   Machida, Haruhiko ^c   Takayama, Morimasa ^a   Sumiyoshi, Tetsuya ^a  

^a Department of Cardiology ^*  (Japan)

^b SAKAKIBARA HEART INSTITUTE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac magnetic resonance; Hypertrophic cardiomyopathy; Independent predictor; Late gadolinium enhancement

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BODY SURFACE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; ELECTROCARDIOGRAPHY; EVALUATION AND FOLLOW UP; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; AGED; ANIMALS; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME;

EID: 84897869078     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0979     Document Type: Article

References (31)

1. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, et al. Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. Circulation 2000; 102: 858-864.
2. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomy-opathy. N Engl J Med 2000; 342: 365-373.
3. Jayatilleke I, Doolan A, Ingles J, McGuire M, Booth V, Richmond DR, et al. Long-term follow-up of implantable cardioverter defibrilla-tor therapy for hypertrophic cardiomyopathy. Am J Cardiol 2004; 93: 1192-1194.
4. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, et al. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212-2218.
5. Maron BJ. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomy-opathy. Circ J 2010; 74: 2271-2282.
6. Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008; 1: 184-191.
7. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010; 3: 51-58.
8. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010; 56: 867-874.
9. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010; 56: 875-887.
10. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic car-diomyopathy. JACC Cardiovasc Imaging 2012; 5: 370-377.
11. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542.
12. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999; 281: 650-655.
13. Maron BJ, Maron MS, Lesser JR, Hauser RG, Haas TS, Harrigan CJ, et al. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol 2008; 101: 544-547.
14. Bongioanni S, Spirito P, Masi AS, Chiribiri A, Bonamini R, Conte MR. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features. Circ Cardiovasc Imaging 2009; 2: 349-350.
15. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007; 298: 405-412.
16. Nakamori S, Matsuoka K, Onishi K, Kurita T, Ichikawa Y, Nakajima H, et al. Prevalence and signal characteristics of late gadolinium enhancement on contrast-enhanced magnetic resonance imaging in patients with takotsubo cardiomyopathy. Circ J 2012; 76: 914-921.
17. Sato T, Tsujino I, Ohira H, Oyama-Manabe N, Yamada Y, Otsuka N, et al. Right atrial late gadolinium enhancement on cardiac magnetic resonance imaging in pulmonary hypertension. Circ J 2012; 76: 238-239.
18. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40: 2156-2164.
19. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 43: 2260-2264.
20. Papavassiliu T, Schnabel P, Schroder M, Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 2005; 26: 2395.
21. Wagner A, Bruder O, Schneider S, Nothnagel D, Buser P, Pons-Lado G, et al. Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson 2009; 11: 43.
22. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopa-thy. Circulation 2006; 114: 216-225.
23. Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopa-thy: Prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 2005; 46: 1543-1550.
24. Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, et al. Assessment and signifcance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2008; 52: 559-566.
25. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic car-diomyopathy. Circulation 2001; 104: 2517-2524.
26. Kubo T, Kitaoka H, Okawa M, Hirota T, Hayato K, Yamasaki N, et al. Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Results from Kochi RYOMA Study. Circ J 2009; 73: 1599-1605.
27. Moon J, Hong YJ, Kim YJ, Shim CY, Jang Y, Chung N, et al. Extent of late gadolinium enhancement on cardiovascular magnetic resonance imaging and its relation to left ventricular longitudinal functional reserve during exercise in patients with hypertrophic cardiomyopathy. Circ J 2013; 77: 1742-1749.
28. Fluechter S, Kuschyk J, Wolpert C, Doesch C, Veltmann C, Haghi D, et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2010; 12: 30.
29. Prinz C, Schwarz M, Ilic I, Laser KT, Lehmann R, Prinz EM, et al. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Can J Cardiol 2013; 29: 358-363.
30. Kwon DH, Setser RM, Popovic ZB, Thamilarasan M, Sola S, Schoenhagen P, et al. Association of myocardial fibrosis, electrocar-diography and ventricular tachyarrhythmia in hypertrophic cardiomy-opathy: A delayed contrast enhanced MRI study. Int J Cardiovasc Imaging 2008; 24: 617-625.
31. Leonardi S, Raineri C, De Ferrari GM, Ghio S, Scelsi L, Pasotti M, et al. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hyper-trophic cardiomyopathy. Eur Heart J 2009; 30: 2003-2010.